Asked by: Bell Ribeiro-Addy (Labour - Clapham and Brixton Hill)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that people with female reproductive systems are informed about symptoms of (a) ovarian and (b) other gynaecological cancers through NHS cervical screening programmes.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
NHS England works to ensure that core public information on screening is easily accessible and understandable to the public, and it regularly and systematically reviews this information.
Earlier this year, NHS England updated its cervical screening guidance to include that cervical screening is not a check for other cancers of the reproductive system, such as ovary, womb, vulval, or vaginal cancer. This guidance is available at the following link:
The guidance advises that you should not wait to contact a general practitioner if you have any concerns.
Asked by: Bell Ribeiro-Addy (Labour - Clapham and Brixton Hill)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether his Department plans to support the domestic (a) collection and (b) processing of (i) blood, (ii) plasma, (iii) cells and (iv) tissues.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
NHS Blood and Transplant (NHSBT) is responsible for blood services in England and also manages the NHS Organ Donor Register (ODR), which includes tissue donation for the supply of human tissue grafts for use in surgery. The Department provides Grant in Aid and seed funding to support NHSBT to grow and diversify donor bases, as well as its capacity to process collections.
Between 1 April 2024 and 31 March 2025, NHSBT met 99.9% of hospital demand for red cells from domestic collections; the remaining 0.01% of units were imported from other United Kingdom blood services.
The Department, NHSBT and NHS England worked together since 2021 to deliver an end-to-end domestic supply chain for plasma-based medicines, enabling UK plasma to be processed into lifesaving medications in specialist facilities in Europe. Since March 2025, this has increased self-sufficiency from 0% to 25% for immunoglobulins and from 0% to 80% for albumin.
The Department’s stem cell programme supports diverse recruitment of UK donors onto the UK Stem Cell Register. A global pool of donors is needed to cover the Human Leukocyte Antigen (HLA) diversity of the population so NHSBT works with international stem cell registries to meet patient demand.
NHSBT works to encourage people to consider signing the ODR including during the upcoming Organ Donation Week between 22 and 26 September 2025. However, there is no mandate for National Health Service establishments to acquire tissue from NHSBT therefore they can acquire from other sources, such as non-UK tissue banks.
Asked by: Bell Ribeiro-Addy (Labour - Clapham and Brixton Hill)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether his Department plans to (a) bring forward modernised UK-specific legislative proposals for Substances of Human Origin (SoHO) and (b) (i) adopt and (ii) adapt relevant elements of the EU’s updated SoHO legislation.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
The Substances of Human Origin (SoHO) Regulation Review Programme launched in 2024 to consider recent changes that the European Union has made to its SoHO Regulation ((EU) 2024/1938) as well as stakeholder proposals for legislation in this area. It is reviewing: patient safety; intra-United Kingdom and UK-EU supply of SoHO; innovation within the sector; and health inequalities.
A key principle of the review is to maintain compatible high levels of minimum safety and quality standards for blood, blood components, tissues and cells, human breast milk, intestinal microbiota and blood preparations that are not used for transfusion, to support public health and the movement of SoHO. A targeted consultation, planned to launch by the end of 2025, will give stakeholders the opportunity to share views and highlight key issues and opportunities.
Asked by: Bell Ribeiro-Addy (Labour - Clapham and Brixton Hill)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, when his Department plans to consult on reforms to the UK’s Substances of Human Origin; and whether that consultation will include proposals on (a) innovation, (b) patient safety and (c) donor protection.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
The Substances of Human Origin (SoHO) Regulation Review Programme launched in 2024 to consider recent changes that the European Union has made to its SoHO Regulation ((EU) 2024/1938) as well as stakeholder proposals for legislation in this area. It is reviewing: patient safety; intra-United Kingdom and UK-EU supply of SoHO; innovation within the sector; and health inequalities.
A key principle of the review is to maintain compatible high levels of minimum safety and quality standards for blood, blood components, tissues and cells, human breast milk, intestinal microbiota and blood preparations that are not used for transfusion, to support public health and the movement of SoHO. A targeted consultation, planned to launch by the end of 2025, will give stakeholders the opportunity to share views and highlight key issues and opportunities.
Asked by: Bell Ribeiro-Addy (Labour - Clapham and Brixton Hill)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, with reference to Imkaan’s report entitled Why Should Our Rage be Tidy, published in November 2024, what steps his Department has taken to help tackle the mental health impacts of violence and abuse on Black and minoritised survivors of violence against women and girls.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
Imkaan’s report reinforces the fact that too many people, including Black and minoritised survivors of domestic abuse and sexual violence, are not receiving the mental health care they need, and that waits for mental health services are too long. We are determined to change that, which is why we have chosen to prioritise funding to expand NHS Talking Therapies. Survivors can access help and support through their general practitioner or by self-referring.
Protecting and supporting victims and survivors of sexual abuse is a core priority for NHS England, delivered through a network of 48 specialist sexual assault referral centres (SARCs) across the country. NHS England commissions SARCs through a distinct national service specification including working with specialist support services, ensuring that children and young people up to the age of 18 years old receive trauma-informed, developmentally appropriate care and safeguarding support, and that adults receive tailored care that reflects their needs and rights, with clear referral pathways to health, justice, and specialist support services. This is in addition to support services commissioned by the Ministry of Justice and the Home Office.
Asked by: Bell Ribeiro-Addy (Labour - Clapham and Brixton Hill)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many sickle cell patients who had complications due to sickle cell listed as their cause of death experienced haemolysis in the period before their death in the last 12 months.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The Department does not hold this information. NHS England does not hold or have access to data that would accurately represent the number of sickle cell patients that have died due to complications due to sickle cell in the last 12 months, or how many of those patients experienced haemolysis in the period before their death in the last 12 months.
The National Disease Registration Service, part of NHS England, is expanding its rare disease collection to include patients with sickle cell disorder (SCD) in England. This will form a comprehensive national dataset to enable improved understanding of patient pathways for SCD, support planning and commissioning of services and improve patient outcomes.
Asked by: Bell Ribeiro-Addy (Labour - Clapham and Brixton Hill)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many sickle cell patients have died due to complications due to sickle cell in the last 12 months.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The Department of Health and Social Care does not hold this information. NHS England does not hold or have access to data that would accurately represent the number of sickle cell patients that have died due to complications due to sickle cell disorder (SCD) in the last 12 months
The National Disease Registration Service, part of NHS England, is expanding its rare disease collection to include patients with SCD in England. This will form a comprehensive national dataset to enable improved understanding of patient pathways for SCD, support planning and commissioning of services and improve patient outcomes.
Asked by: Bell Ribeiro-Addy (Labour - Clapham and Brixton Hill)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what recent discussions he has had with the NHS on its policy of informing Sickle Cell patients when they are not given Ro matched blood.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
DHSC are working in partnership with NHS Blood and Transplant, NHS England and the National Blood Transfusion Committee to deliver on the recommendations detailed in the infected blood inquiry, which includes improving digital patient records and communications for patients receiving transfusions. A blood genotyping programme has also been introduced, enabling detection of previously undetectable antibodies that could cause complications. To meet the clinical need to provide better matched blood for patients with conditions like sickle cell disorder, NHS Blood and Transplant is actively recruiting donors from Black heritage backgrounds.
Asked by: Bell Ribeiro-Addy (Labour - Clapham and Brixton Hill)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, with reference to Imkaan’s report entitled Why should our rage be tidy, published in November 2024, whether (a) black and (b) minoritised survivors of domestic abuse are informed of by and for support services by their GP.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
Imkaan’s report highlights the distinct and additional challenges faced by black and minoritised victims of domestic abuse and sexual violence. The Government recognises that racial health inequalities are linked to broader socioeconomic factors. Tackling these inequalities is central to building a fairer health system where outcomes are not dictated by race or background. That is why NHS England has introduced a framework for integrated care boards (ICBs) to reduce disparities in outcomes and improve access to treatments.
All National Health Service staff, including general practitioners (GPs), are required to complete mandatory safeguarding training which includes how to identify, support and respond to domestic abuse and sexual violence. Safeguarding Leads within local NHS trusts, ICBs and general practices are responsible for ensuring practitioners are offering appropriate professional advice, support, and assurance to prevent harm, including onward referrals to specialist support services. Commissioning of support services for victims of abuse should be tailored to meet the needs and demographics of the local population.
Asked by: Bell Ribeiro-Addy (Labour - Clapham and Brixton Hill)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps her Department has taken to ensure (a) GPs and (b) mental health professionals are trained in (i) identifying and (ii) responding to the (A) traumatic physical and emotional impacts of violence and abuse and (B) the specific consequences of abuse for Black and minoritised victims.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
All National Health Service staff are required to complete mandatory safeguarding training which includes how to identify and respond to domestic abuse and sexual violence. This training is being revised and is due to be re-launched in early 2026. The training update will strengthen the importance of intersectional considerations, including helping staff to understand the impact of trauma and cultural barriers to discussing abuse.
General practitioners, along with other clinicians in the NHS, support victims and survivors of abuse in a range of ways depending on diagnosis and individual needs. This may include treating abuse-related injuries, referral to mental health treatment, or referral to a psychological support service such as peer support.
All mental health service providers are expected to embed the Patient and carer race equality framework. This mandatory framework supports trusts and providers to implement actions to reduce racial inequalities within their services. It will become part of Care Quality Commission inspections. The Framework is available at the following link:
https://www.england.nhs.uk/publication/patient-and-carer-race-equality-framework/
Most integrated care boards and NHS trusts have appointed domestic abuse and sexual violence leads. They comprise a national network of leaders who share good practice, identify issues and develop solutions to support victim and survivors, including those from Black and minority groups.